#C5aR - Twitter Hashtag

@StreetCred2018

@StreetCred2017

11 months ago

@Sonicconcept1 There’s a lotta ppl who drank the cool aid and have been in 5-6 year wouldn’t dare sell now. Never seen quite a cult following $IFRX @Quick2smile @3in5saved @O248528307 #INF904 #C5aR

1

3

0

402

CSIMarket.com @CSIMarket

over 2 years ago

#IFRX #C5aR #InflarxNv #IFRX #ClinicalStudy Unveiling the Promise: InflaRx's INF904 Sets New Benchmarks as a Best-in-Class C5aR Inhibitor: $IFRX Inflammation is a complex immune response that plays a crucial role in various diseases, including… https://t.co/kNZapAV5gP

CSIMarket's tweet photo. #IFRX #C5aR #InflarxNv #IFRX #ClinicalStudy Unveiling the Promise: InflaRx's INF904 Sets New Benchmarks as a Best-in-Class C5aR Inhibitor: $IFRX Inflammation is a complex immune response that plays a crucial role in various diseases, including… https://t.co/kNZapAV5gP https://t.co/YAeYLmiAgf

0

2

1

0

185

I-Mab Biopharma @IMabBiopharma

almost 6 years ago

I-Mab announced preclinical data from studies of TJ210, an anti-C5aR monoclonal #antibody investigated in partnership with MorphoSys. The studies show that the unique binding to epitope on #C5aR is able to inhibit #tumor growth in mouse models: https://t.co/ICBq4O9ttQ #SITC2020

IMabBiopharma's tweet photo. I-Mab announced preclinical data from studies of TJ210, an anti-C5aR monoclonal #antibody investigated in partnership with MorphoSys. The studies show that the unique binding to epitope on #C5aR is able to inhibit #tumor growth in mouse models: https://t.co/ICBq4O9ttQ #SITC2020 https://t.co/rIrZsFkX5Y

0

2

0

Marseille Immunopole @Immunopole

almost 6 years ago

#SITC2020 We are very proud of presentations made this year by Marseille Immunopole partners! with @InnatePharma in #COVID19 , @ImcheckThx with its #ICT01 @firstinhuman trial in #ImmunoOncology with the support of @HalioDx #C5ar #Butyrophilins #γδTCells #immunoscore @sitcancer

Immunopole's tweet photo. #SITC2020 We are very proud of presentations made this year by Marseille Immunopole partners!
with @InnatePharma in #COVID19 , @ImcheckThx with its #ICT01 @firstinhuman trial in #ImmunoOncology with the support of @HalioDx
#C5ar #Butyrophilins #γδTCells #immunoscore @sitcancer https://t.co/MhWFpCXySo

0

8

3

0

Andrew @andrewkwil

almost 6 years ago

Role of C5aR1 and C5aR2 in gut ischaemia-reperfusion. #C5aR #C5a #C5aR2 #C5L2 $ifrx $ccxi

NeuroComplement_Lab @neurocomplement

almost 6 years ago

This receptor keeps on surprising! C5aR2 is protective in gut ischemia-reperfusion injury. “Absence of the C5a receptor C5aR2 worsens ischemic tissue injury by increasing C5aR1-mediated neutrophil infiltration” Work published on @J_Immunol @JohnDGLee https://t.co/FuZZK9pfyX

0

11

3

1

0

2

4

0

1

0

Andrew @andrewkwil

almost 6 years ago

Rhabdomyolysis induced acute kidney injury (RIAKI) and complement. The opportunities with complement inhibition are astounding. Very interesting read. #lectinpathway #masp2 #c5ar $ccxi $omer $alxn $cbio $apls

Lubka Roumenina @roumenina

almost 6 years ago

Trilled to see our paper in @Kidney_Int showing the pathogenic role of #complementbiology in the rhabdomyolysis induced acute kidney injury. Fantastic work of @BoudhabhayI @VPoillerat A. Grunenwald and all collaborators! https://t.co/U8xw8aF64y

2

28

7

1

0

1

6

4

0

Trends in Biochemical Sciences @TrendsBiochem

over 6 years ago

Online now - the Review "Emerging Insights into the Structure and Function of #Complement C5a Receptors" from @Shubhip97 @arshukla and colleagues! #GPCRs #functionalbias #C5aR https://t.co/JSmDnbIWCw

TrendsBiochem's tweet photo. Online now - the Review "Emerging Insights into the Structure and Function of #Complement C5a Receptors" from @Shubhip97 @arshukla and colleagues!

#GPCRs #functionalbias #C5aR
https://t.co/JSmDnbIWCw https://t.co/f9gbM7ddfN

0

6

1

0

jptissierseta @jptissierseta

over 6 years ago

Results of #ExploreCovid19 translational study https://t.co/OqLIwmMJoW: B, T & NK #lymphopenia increases with the severity of the disease; #SARSCoV2 induces #CD39 #PD1 & #NKG2A #ImmuneCheckpoints; the #C5a/#C5aR-dependent #MyeloidPathway plays a key role in the #CytokineStorm

Marseille Immunopole @Immunopole

over 6 years ago

#NextGenerationImmunology @JuCarvelli #IntensiveCare Physician & #Immunologist https://t.co/0W5JEYde9m #ExploreCovid19 study #ForceCovid19 #clinicaltrial with #antiC5aR #avdoralimab in #Covid19 patients with #SeverePneumonia @aphm_actu @Immunopole @HopitalLaveran @InnatePharma

Immunopole's tweet photo. #NextGenerationImmunology @JuCarvelli #IntensiveCare Physician & #Immunologist https://t.co/0W5JEYde9m #ExploreCovid19 study #ForceCovid19 #clinicaltrial with #antiC5aR #avdoralimab in #Covid19 patients with #SeverePneumonia @aphm_actu @Immunopole @HopitalLaveran @InnatePharma https://t.co/qg4LzkXewc

0

21

5

0

SATOSHI @satoshi0115

over 6 years ago

PAR2阻害剤であるAZ8838とAZ3451を期待しており、C5a受容体阻害剤はCOVID19に対して非常に効果的であると考えています。 #SOSEIHEPTARES #nature #C5aR …ほほう？🤔

もくもくもっくん @mokumok98085243

over 6 years ago

I would like to expect PAR2 inhibitors, AZ8838 and AZ3451, and consider C5a Receptor inhibitors are quite effective against COVID19. #SOSEIHEPTARES #nature #C5aR https://t.co/Bv0OfmVFSr

1

29

5

0

22

2

0

もくもくもっくん @mokumok98085243

over 6 years ago

I would like to expect PAR2 inhibitors, AZ8838 and AZ3451, and consider C5a Receptor inhibitors are quite effective against COVID19. #SOSEIHEPTARES #nature #C5aR https://t.co/Bv0OfmVFSr

1

29

5

0